Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 GBX | 0.00% | 0.00% | -53.12% |
26/04 | Evgen Pharma plc will Change its Ticker to TCF from EVG | CI |
26/04 | Evgen Pharma plc will Change its Name to TheraCryf plc | CI |
Sales 2024 * | 486K 40.58M | Sales 2025 * | - | Capitalization | 4.01M 335M |
---|---|---|---|---|---|
Net income 2024 * | -4M -334M | Net income 2025 * | - | EV / Sales 2024 * | 3.76 x |
Net cash position 2024 * | 2.19M 183M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.59
x | P/E ratio 2025 * |
-
| Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.58% |
3 months | -34.78% | ||
6 months | -58.33% | ||
Current year | -53.12% |
Managers | Title | Age | Since |
---|---|---|---|
Huw Jones
CEO | Chief Executive Officer | 62 | - |
Toni Haenninen
DFI | Director of Finance/CFO | - | 05/23/05 |
Glen Clack
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Huw Jones
CEO | Chief Executive Officer | 62 | - |
Susan Foden
CHM | Chairman | 71 | 21/14/21 |
Alan Barge
BRD | Director/Board Member | - | 21/15/21 |
Date | Price | Change | Volume |
---|---|---|---|
10/24/10 | 0.75 | 0.00% | 50,000 |
09/24/09 | 0.75 | 0.00% | 7,200 |
08/24/08 | 0.75 | 0.00% | 106,983 |
07/24/07 | 0.75 | 0.00% | 296,635 |
03/24/03 | 0.75 | 0.00% | 14,825 |
Delayed Quote London S.E., May 10, 2024 at 09:05 pm IST
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-53.12% | 4.01M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- EVG Stock